This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Prestige Brands Named To Fortune List Of 100 Fastest Growing Companies

Fortune® has named Prestige Brands Holdings, Inc. (NYSE-PBH) as one of its 100 fastest growing companies. Listed as #60, PBH markets and distributes brand name over-the-counter healthcare products throughout the U.S., Canada, and in certain international markets.

The Fortune list measures companies by growth in revenue, profit and stock price over the past three years. Prestige’s strong financial performance included a 30% revenue growth, 30% adjusted EPS growth and 60% total return for the three-year period.

“Our strategy for creating shareholder value has three prongs which work in tandem: invest in and grow our core over-the-counter healthcare brands, harness our financial profile and industry-leading free cash flow to pay down debt and build M&A capacity, and remain aggressive and disciplined in the M&A market,” said Matthew M. Mannelly, CEO. “The successful execution of this strategy worked to create the results for which we are recognized on this important Fortune list,” he said.

Prestige Brands is the largest independent publicly-traded OTC products company in America. The company’s core brands include Chloraseptic ® sore throat treatments, Clear Eyes ® eye care products, Compound W ® wart treatments, Little Remedies ® and PediaCare ® pediatric over-the-counter healthcare products, The Doctor’s ® NightGuard® dental protector, Efferdent ® denture care products, Luden’s ® throat drops, Dramamine ® motion sickness treatment, BC ® and Goody’s ® headache remedies, Beano ® gas prevention, Debrox ® earwax remover, and in Canada, Gaviscon ® antacid. (Fortune is a registered trademark of Time Inc.)

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,686.22 -43.89 -0.25%
S&P 500 2,066.05 -10.73 -0.52%
NASDAQ 4,983.7590 -25.4550 -0.51%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs